CRISIL assigns valuation grade of 5/5 to Plethico Pharma

CRISIL Research has come out with its report on Plethico Pharmaceuticals. The research firm has initiated coverage on Plethico Pharmaceuticals with a Valuation Grade of ‘5/5’ and maintain the fair value of Rs 530 per share.

April 26, 2011 / 19:09 IST

26 Aug, 2025 12:21

Volume

Todays L/H

CRISIL Research has come out with its report on Plethico Pharmaceuticals. The research firm has initiated coverage on Plethico Pharmaceuticals with a Valuation Grade of

first published: Apr 26, 2011 07:00 pm

Discover the latest Business News, Sensex, and Nifty updates. Obtain Personal Finance insights, tax queries, and expert opinions on Moneycontrol or download the Moneycontrol App to stay updated!

Advisory Alert: It has come to our attention that certain individuals are representing themselves as affiliates of Moneycontrol and soliciting funds on the false promise of assured returns on their investments. We wish to reiterate that Moneycontrol does not solicit funds from investors and neither does it promise any assured returns. In case you are approached by anyone making such claims, please write to us at grievanceofficer@nw18.com or call on 02268882347